GE Healthcare announced FDA approval of ioflupane I-123 injection (DaTscan), a SPECT imaging contrast agent for detecting dopamine transporters in suspected parkinsonian syndromes.

According to Houston Methodist Hospital, the imaging agent’s activity in a normal scan will appear as mirrored comma or crescent shapes if sufficient dopamine transporters (DaT) are intact or ...

A new brain imaging procedure now in use at Halifax Health Medical Center could lead to improved early diagnosis and treatment for those afflicted with Parkinson's.

A new imaging test - called DAT-scan - is giving doctors a glimpse inside the Parkinson's brain. First doctors inject patients with a tracer.